Integrated BioPharma, Inc. (INBP)

OTCMKTS: INBP · Delayed Price · USD
0.215
0.00 (0.00%)
Apr 9, 2024, 11:42 AM EDT - Market closed
Market Cap 6.47M
Revenue (ttm) 62.60M
Net Income (ttm) -385,000
Shares Out 30.10M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 600
Open 0.181
Previous Close 0.215
Day's Range 0.181 - 0.215
52-Week Range 0.170 - 0.380
Beta 0.51
Analysts n/a
Price Target n/a
Earnings Date n/a

About INBP

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional produ... [Read more]

Industry Packaged Foods
IPO Date Oct 29, 1996
Employees 141
Stock Exchange OTCMKTS
Ticker Symbol INBP
Full Company Profile

Financial Performance

Financial Statements

News

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023

HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the...

2 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023

HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023. Revenue for the...

5 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023

HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023. Re...

7 months ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023

HILLSIDE, NJ / ACCESSWIRE / May 11, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2023. Revenue for the quarter...

1 year ago - Accesswire

Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President

HILLSIDE, NJ / ACCESSWIRE / March 21, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced that Edward G. Kay, the Company's Founder, Executive Chairman and President pas...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022

HILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2022. Revenue for th...

1 year ago - Accesswire

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022

HILLSIDE, NJ / ACCESSWIRE / November 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2022. Revenue for th...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022

HILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022. Re...

1 year ago - Accesswire

Integrated BioPharma Announces Change in Directors

HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Bo...

1 year ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

HILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the ...

2 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021

HILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the...

2 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021

HILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for th...

2 years ago - Accesswire

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021

HILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021. Rev...

2 years ago - Accesswire

OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX: IN...

Other symbols: OTCM
3 years ago - PRNewsWire